We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Groundbreaking AI-Based Method Accurately Classifies Cardiac Function and Disease Using Chest X-Rays

By MedImaging International staff writers
Posted on 07 Jul 2023
Image: An artificial intelligence-based model classifies cardiac functions from chest radiographs (Photo courtesy of Osaka Metropolitan University)
Image: An artificial intelligence-based model classifies cardiac functions from chest radiographs (Photo courtesy of Osaka Metropolitan University)

Valvular heart disease, a leading cause of heart failure, is commonly diagnosed using echocardiography. However, this technique demands specialized expertise, leading to a shortage of proficient technicians. Chest radiography, on the other hand, is a widely used diagnostic method for identifying primarily lung diseases. Even though the heart is visible in chest radiographs or chest X-rays, its potential to detect cardiac function or disease has been largely unexplored until now. Given their widespread use, rapid execution, and high reproducibility, chest X-rays could serve as a supplementary tool to echocardiography for diagnosing cardiac conditions if they could accurately determine cardiac function and disease. Now, an innovative artificial intelligence (AI) tool uses chest X-rays to classify cardiac functions and identify valvular heart disease with unprecedented accuracy.

Scientists at Osaka Metropolitan University (Osaka, Japan) have developed an AI-based model capable of accurately classifying cardiac functions and diagnosing valvular heart diseases using chest X-rays. Given the potential for bias and resultant low accuracy if AI is trained on a single dataset, the team collected a multi-institutional dataset comprising 22,551 chest X-rays and corresponding echocardiograms from 16,946 patients across four facilities between 2013 and 2021. The AI model was trained using chest X-rays as input data and the corresponding echocardiograms as output data, enabling it to learn the features connecting the two datasets.

The AI model succeeded in precisely classifying six selected types of valvular heart disease, with the Area Under the Curve (AUC is a rating index denoting an AI model's capability with a value range from 0 to 1—the closer to 1, the better) ranging from 0.83 to 0.92. The AUC was 0.92 at a 40% cut-off for detecting left ventricular ejection fraction—an essential metric for monitoring cardiac function.

“It took us a very long time to get to these results, but I believe this is significant research,” stated Dr. Daiju Ueda from Osaka Metropolitan University who led the research team. “In addition to improving the efficiency of doctors’ diagnoses, the system might also be used in areas where there are no specialists, in night-time emergencies, and for patients who have difficulty undergoing echocardiography.”

Related Links:
Osaka Metropolitan University 

Computed Tomography System
Aquilion ONE / INSIGHT Edition
Ultrasonic Pocket Doppler
SD1
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
Radiation Safety Barrier
RayShield Intensi-Barrier

Channels

Ultrasound

view channel
Image: The super-resolution lymphatic imaging system could diagnose and monitor patients with lymphatic disease (Photo courtesy of Adobe Stock)

Portable Imaging Scanner to Diagnose Lymphatic Disease in Real Time

Lymphatic disorders affect hundreds of millions of people worldwide and are linked to conditions ranging from limb swelling and organ dysfunction to birth defects and cancer-related complications.... Read more

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.